ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
1-Year Return
45.88%
This Quarter Return
-23.69%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$36.2M
AUM Growth
-$72M
(-67%)
Cap. Flow
-$54.2M
Cap. Flow
% of AUM
-149.85%
Top 10 Holdings %
Top 10 Hldgs %
74.48%
Holding
38
New
3
Increased
2
Reduced
18
Closed
15
Top Buys
| 1 |
Inogen
INGN
|
$1.25M |
| 2 |
Equillium
EQ
|
$497K |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$405K |
| 4 |
Insmed
INSM
|
$171K |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$133K |
Top Sells
| 1 |
Acadia Healthcare
ACHC
|
$6.57M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$3.72M |
| 3 |
AnaptysBio
ANAB
|
$3.31M |
| 4 |
Pfizer
PFE
|
$3.01M |
| 5 |
Natera
NTRA
|
$2.98M |
Sector Composition
| 1 | Healthcare | 83.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ionis Pharmaceuticals
IONS
$9.77B
| – | – |
-37,021
| Closed | -$1.91M |
|
|
27
Jazz Pharmaceuticals
JAZZ
$7.85B
| – | – |
-22,144
| Closed | -$3.72M |
|
|
28
Natera
NTRA
$23.2B
| – | – |
-124,517
| Closed | -$2.98M |
|
29
OraSure Technologies
OSUR
$236M
| – | – |
-179,496
| Closed | -$2.77M |
|
|
30
Pfizer
PFE
$140B
| – | – |
-72,000
| Closed | -$3.01M |
|
31
Sarepta Therapeutics
SRPT
$1.94B
| – | – |
-14,508
| Closed | -$2.34M |
|
32
Neuronetics
STIM
$215M
| – | – |
-45,292
| Closed | -$1.45M |
|
33
Vertex Pharmaceuticals
VRTX
$101B
| – | – |
-12,650
| Closed | -$2.44M |
|
|
NVRO
34
DELISTED
NEVRO CORP.
NVRO
| – | – |
-31,379
| Closed | -$1.79M |
|
|
GRTS
35
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – |
-20,000
| Closed | -$285K |
|
|
NVTA
36
DELISTED
Invitae Corporation
NVTA
| – | – |
-105,072
| Closed | -$1.76M |
|
|
UROV
37
DELISTED
Urovant Sciences Ltd.
UROV
| – | – |
-158,463
| Closed | -$1.9M |
|
|
ECYT
38
DELISTED
Endocyte, Inc. Common Stock
ECYT
| – | – |
-96,297
| Closed | -$1.71M |
|